Hoch Lynelle Insider Trading -- Recent SEC Form 4 Transactions

Hoch Lynelle (CIK 2005382) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-12). Recent activity: Sell BMY (94 shares), Sell BMY (212 shares), Buy BMY (1,050 shares), Sell BMY (113 shares), Sell BMY (267 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell94$0
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell212$12,748
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy1,050$0
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell113$0
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell267$16,055
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy6,304$0
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell3,095$0
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell912$54,839
2026-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy838$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell296$18,681
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy546$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell38$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell219$13,821
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy835$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell146$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy1,050$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell179$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell374$23,603
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Buy5,015$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell1,850$0
2025-03-12BRISTOL MYERS SQUIBB CO (BMY)President, Cell Therapy Org.Sell1,359$85,766

Source: SEC Form 4 filings · as of 2026-03-12